Certain flexibilities to the 340B program allowed under the COVID-19 public health emergency will expire May 11 alongside the PHE, the U.S. Health Resources and Services Administration announced Monday.
The update, which HRSA posted prominently on the Office of Pharmacy Affairs website yesterday, confirms the end of three years of specific flexibilities afforded to 340B entities during the COVID-19 pandemic. HRSA said 340B stakeholders that believe the PHE expiration will adversely affect their 340B compliance or enrollment should contact the 340B Prime Vendor for evaluation on a case-by-case basis.
Certain flexibilities to the 340B program allowed under the COVID-19 public health emergency will expire May 11 alongside the PHE, the U.S. Health Resources and Services Administration announced Monday. The update, which HRSA posted prominently on the Office of Pharmacy […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
